These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6375079)

  • 1. Mode of action of Emcyt.
    Høisaeter PA
    Urology; 1984 Jun; 23(6 Suppl):46-8. PubMed ID: 6375079
    [No Abstract]   [Full Text] [Related]  

  • 2. Estramustine phosphate (Estracyt): experimental and clinical studies in Europe.
    Hoisaeter PA; Bakke A
    Semin Oncol; 1983 Sep; 10(3 Suppl 3):27-33. PubMed ID: 6364363
    [No Abstract]   [Full Text] [Related]  

  • 3. Estracyt--mode of action and clinical experience.
    Hedlund PO
    Prog Clin Biol Res; 1987; 243B():215-9. PubMed ID: 3309981
    [No Abstract]   [Full Text] [Related]  

  • 4. Specific binding of estramustine to prostatic proteins.
    Forsgren B; Björk P
    Urology; 1984 Jun; 23(6 Suppl):34-8. PubMed ID: 6375077
    [No Abstract]   [Full Text] [Related]  

  • 5. Intracellular effects of estramustine (Estracyt/Emcyt).
    Tew KD; Stearns ME
    Prog Clin Biol Res; 1989; 303():169-75. PubMed ID: 2674983
    [No Abstract]   [Full Text] [Related]  

  • 6. Estramustine--current status, 1983.
    Ahlgren JD
    Semin Oncol; 1983 Sep; 10(3 Suppl 3):46-7. PubMed ID: 6364367
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on the estramustine-binding protein in rat ventral prostate and in human prostate.
    Gustafsson JA; Björk P; Carlström K; Forsgren B; Hökfelt T; Pousette A; Högberg B
    Scand J Urol Nephrol Suppl; 1980; 55():133-4. PubMed ID: 6163205
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition by estramustine phosphate on estradiol and androgen binding in benign and malignant prostate in humans.
    Nilsson I; Liskowski L; Nilsson T
    Urology; 1976 Aug; 8(2):118-21. PubMed ID: 60819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estramustine phosphate: metabolic aspects related to its action in prostatic cancer.
    Kadohama N; Kirdani RY; Murphy GP; Sandberg AA
    J Urol; 1978 Feb; 119(2):234-9. PubMed ID: 633484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacology and metabolism of a new therapeutic drug for prostatic cancer "Estracyt"].
    Yamanaka H; Shida K
    Gan To Kagaku Ryoho; 1984 Mar; 11(3):537-44. PubMed ID: 6422861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial characterization and "quantitation" of a human prostatic estramustine-binding protein.
    Björk P; Forsgren B; Gustafsson JA; Pousette A; Högberg B
    Cancer Res; 1982 May; 42(5):1935-42. PubMed ID: 7066904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estramustine-binding protein in rat and human prostate.
    Forsgren B
    Scand J Urol Nephrol Suppl; 1988; 107():56-8. PubMed ID: 3287598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic aspects and actions unique to Estracyt.
    Sandberg AA
    Semin Oncol; 1983 Sep; 10(3 Suppl 3):3-15. PubMed ID: 6364364
    [No Abstract]   [Full Text] [Related]  

  • 14. Testosterone-induced DNA synthesis in cultured rat ventral prostate: effects of estracyt and its derivatives.
    Buchanan LJ; Riches AC
    Br J Cancer; 1987 Jan; 55(1):47-51. PubMed ID: 3814475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of androgen receptor and estramustine binding protein of rat ventral prostatic tissue in organ culture.
    Høisaeter PA; Kadohama N; Corrales JJ; Karr JP; Murphy GP; Sandberg AA
    J Steroid Biochem; 1981 Mar; 14(3):251-60. PubMed ID: 7218791
    [No Abstract]   [Full Text] [Related]  

  • 16. Estramustine: historical background and preclinical trials.
    Schein PS
    Semin Oncol; 1983 Sep; 10(3 Suppl 3):1-2. PubMed ID: 6686721
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of a steroidal alkylating agent (estramustine phosphate) in rat ventral prostate.
    Høisaeter PA
    Scand J Urol Nephrol Suppl; 1977; (46):1-72. PubMed ID: 279091
    [No Abstract]   [Full Text] [Related]  

  • 18. Estramustine. Metabolic pattern and possible mechanisms for its action in prostate cancer.
    Kadohama N; Kirdani RY; Madajewicz S; Murphy GP; Sandberg AA
    N Y State J Med; 1979 Jun; 79(7):1005-9. PubMed ID: 287893
    [No Abstract]   [Full Text] [Related]  

  • 19. An immunohistochemical technique for localization and semiquantitation of estramustine-binding protein (EMBP) in rat and human prostate.
    Bichler KH; Flüchter SH; Nelde HJ; Björk P; Müntzing J
    Prostate; 1989; 14(1):13-25. PubMed ID: 2467273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of diethylstilbestrol and estramustine phosphate on serum sex hormone binding globulin and testosterone levels in prostate cancer patients.
    Karr JP; Wajsman Z; Kirdani RY; Murphy GP; Sandberg AA
    J Urol; 1980 Aug; 124(2):232-6. PubMed ID: 7190620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.